AT Capital Group

AT Capital Group is a family office based in Singapore. The firm targets public & private market securities in debt, equity, metals, and other liquid assets and strategic mid- to long-term investments in real estate and renewable energy sectors.

Sanjay Bakliwal

Director

Arvind Tiku

Founder and Group Chairman

4 past transactions

Akselos

Venture Round in 2022
Akselos S.A. is a developer of advanced engineering simulation software, specifically the Integra platform, which is designed for asset-centric industries such as oil and gas and offshore wind. Founded in 2011 and headquartered in Lausanne, Switzerland, with additional offices in Vietnam and Cambridge, Massachusetts, Akselos offers a cloud-based solution that allows engineers to create high-resolution simulations for large industrial systems. The platform enables users to construct detailed 3D models, perform hydrodynamic analyses, assess structural integrity, and analyze composite materials used in various applications. Akselos leverages patented algorithms that significantly enhance simulation speed and accuracy, aiming to facilitate preventative maintenance and optimize asset management by providing real-time insights into the condition of critical infrastructure.

ObvioHealth

Series B in 2021
ObvioHealth is a clinical research platform focused on enhancing the efficiency of the clinical trial process. By leveraging advanced technology, the platform enables sponsors to obtain superior data while providing participants with a more convenient trial experience, allowing them to engage in virtual clinical trials from their homes. Supported by SPRIM, a global leader in health-centric innovation with extensive expertise in medical and life sciences, ObvioHealth benefits from a strong foundation in digital capabilities and regulatory knowledge. This collaboration aims to drive disruptive innovations and facilitate new market entries, ultimately striving to deliver tangible results in the clinical research landscape.

Fibronostics

Series A in 2020
Fibronostics is a global diagnostics company, providing non-invasive, algorithmic diagnostics, and insights to detect and manage organ lesions caused by metabolic diseases. The company leverages artificial intelligence to screen and measure the progression and prognosis of liver & kidney disease as well as other chronic conditions.

Lenddo

Series B in 2015
Lenddo International operates an online platform that enables users to leverage their social connections to build creditworthiness and access financial services in emerging markets. By utilizing reputation data from social networks such as Facebook and LinkedIn, Lenddo helps individuals secure loans for purposes such as education, debt consolidation, and small business ventures. Founded in 2011, the company primarily serves customers in Colombia and the Philippines, with its headquarters in Central, Hong Kong, and additional offices in Manila, Bogotá, and New York City. As of October 2017, Lenddo International is a subsidiary of EFL Global LTD.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.